Yes I have considered this in the past. This combo is incredibly effective at treating the cancer, but it comes with a very high cardiac risk. Bisantrene might be able to change this by keeping the anticancer efficacy, but minimising the cardiac damage.
The complication is the introduction of Enhertu which has upturned the whole HER2 treatment landscape.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-81
-
- There are more pages in this discussion • 825 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.78 |
Change
-0.040(2.20%) |
Mkt cap ! $302.5M |
Open | High | Low | Value | Volume |
$1.81 | $1.82 | $1.76 | $132.8K | 74.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 170 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.78 | 2 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 170 | 1.765 |
2 | 4000 | 1.755 |
3 | 12714 | 1.750 |
1 | 3000 | 1.740 |
1 | 1405 | 1.720 |
Price($) | Vol. | No. |
---|---|---|
1.775 | 2 | 1 |
1.780 | 3781 | 1 |
1.820 | 2315 | 1 |
1.830 | 7500 | 1 |
1.840 | 1000 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |